Clarius Group LLC’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.16M | Hold |
368,995
| – | – | 0.3% | 40 |
|
|
2025
Q1 | $5.02M | Sell |
368,995
-41,000
| -10% | -$557K | 0.32% | 40 |
|
|
2024
Q4 | $8.36M | Hold |
409,995
| – | – | 0.57% | 28 |
|
|
2024
Q3 | $11.9M | Hold |
409,995
| – | – | 0.84% | 19 |
|
|
2024
Q2 | $9.52M | Buy |
409,995
+17,777
| +5% | +$413K | 0.67% | 22 |
|
|
2024
Q1 | $8.05M | Buy |
392,218
+13,956
| +4% | +$286K | 0.56% | 27 |
|
|
2023
Q4 | $8.12M | Hold |
378,262
| – | – | 0.67% | 26 |
|
|
2023
Q3 | $7.8M | Sell |
378,262
-5
| -0% | -$103 | 0.74% | 24 |
|
|
2023
Q2 | $11.2M | Buy |
378,267
+87,937
| +30% | +$2.6M | 0.86% | 18 |
|
|
2023
Q1 | $6.69M | Buy |
290,330
+29,726
| +11% | +$685K | 0.57% | 25 |
|
|
2022
Q4 | $7.25M | Hold |
260,604
| – | – | 0.65% | 24 |
|
|
2022
Q3 | $8M | Buy |
260,604
+232,085
| +814% | +$7.12M | 0.8% | 20 |
|
|
2022
Q2 | $839K | Buy |
28,519
+2,074
| +8% | +$61K | 0.08% | 145 |
|
|
2022
Q1 | $1.18M | Hold |
26,445
| – | – | 0.09% | 118 |
|
|
2021
Q4 | $1.18M | Buy |
26,445
+13,750
| +108% | +$613K | 0.09% | 118 |
|
|
2021
Q3 | $640K | Buy |
12,695
+8,562
| +207% | +$432K | 0.06% | 179 |
|
|
2021
Q2 | $324K | Buy |
+4,133
| New | +$324K | 0.03% | 299 |
|